Covered recipient · General Payments record
ALIREZA NAMI
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$48,086.15
- Reported across 753 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $652.16 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $309.37 | 16 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $70.60 | 3 |
| ABBVIE INC. | $53.72 | 2 |
| Lilly USA, LLC | $46.03 | 2 |
| UCB, Inc. | $43.58 | 2 |
| PFIZER INC. | $33.92 | 2 |
| GlaxoSmithKline, LLC. | $23.73 | 1 |
| Organon LLC | $19.42 | 1 |
| Fresenius Kabi USA, LLC | $18.14 | 1 |
| Acerta Pharma LLC | $17.32 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.75 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105097617 | CMS |
| ABBVIE INC. | $25.97 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105097619 | CMS |
| Amgen Inc. | $9.17 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117336572 | CMS |
| Amgen Inc. | $17.54 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659641 | CMS |
| Amgen Inc. | $13.05 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659627 | CMS |
| Amgen Inc. | $15.10 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659631 | CMS |
| Amgen Inc. | $8.73 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659637 | CMS |
| Amgen Inc. | $97.42 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117336574 | CMS |
| Amgen Inc. | $18.59 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659643 | CMS |
| Amgen Inc. | $7.05 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659639 | CMS |
| Amgen Inc. | $15.74 | 07/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659645 | CMS |
| Amgen Inc. | $18.48 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659647 | CMS |
| Amgen Inc. | $9.76 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659649 | CMS |
| Amgen Inc. | $12.16 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659629 | CMS |
| Amgen Inc. | $12.88 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659633 | CMS |
| Amgen Inc. | $19.37 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659651 | CMS |
| Amgen Inc. | $6.04 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659653 | CMS |
| Amgen Inc. | $28.29 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111659635 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.32 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110536054 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.33 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101834006 | CMS |
| Fresenius Kabi USA, LLC | $18.14 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146944045 | CMS |
| GlaxoSmithKline, LLC. | $23.73 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116359716 | CMS |
| Lilly USA, LLC | $27.00 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136023374 | CMS |
| Lilly USA, LLC | $19.03 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136028584 | CMS |
| Novartis Pharmaceuticals Corporation | $19.09 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086961556 | CMS |
| Novartis Pharmaceuticals Corporation | $26.29 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086961558 | CMS |
| Novartis Pharmaceuticals Corporation | $25.22 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086961560 | CMS |
| Organon Llc | $19.42 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136201207 | CMS |
| PFIZER INC. | $17.81 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131127791 | CMS |
| PFIZER INC. | $16.11 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131212603 | CMS |
| UCB, Inc. | $22.96 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143116595 | CMS |
| UCB, Inc. | $20.62 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143116597 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.